Vipul Organics（530627）株式概要Vipul Organics Limitedはインドで染料、有機顔料、有機中間体の製造・販売を行っている。 詳細530627 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績3/6財務の健全性5/6配当金3/6報酬過去1年間で収益は56.1%増加しました リスク分析過去5年間で収益は年間7%減少しました。 高いレベルの非現金収入 0.32%の配当はフリーキャッシュフローで十分にカバーされていない 意味のある時価総額がありません ( ₹5B )すべてのリスクチェックを見る530627 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW485,335 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINROAG485,335 investors already sharing narrativesYour Fair Value₹Current Price₹250.55267.4% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture02b2016201920222025202620282031Revenue ₹2.4bEarnings ₹93.4mAdvancedSet Fair ValueView all narrativesVipul Organics Limited 競合他社DIC IndiaSymbol: BSE:500089Market cap: ₹4.5bPlastiblends IndiaSymbol: BSE:523648Market cap: ₹4.4bKronox Lab SciencesSymbol: NSEI:KRONOXMarket cap: ₹5.4bJayant Agro-OrganicsSymbol: NSEI:JAYAGROGNMarket cap: ₹6.2b価格と性能株価の高値、安値、推移の概要Vipul Organics過去の株価現在の株価₹250.5552週高値₹309.0052週安値₹156.80ベータ0.151ヶ月の変化-7.17%3ヶ月変化39.70%1年変化6.55%3年間の変化133.40%5年間の変化51.55%IPOからの変化4,374.11%最新ニュースNew Risk • Jun 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 7.0% per year over the past 5 years. High level of non-cash earnings (25% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (₹5.14b market cap, or US$54.0m).Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹241, the stock trades at a trailing P/E ratio of 66.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 187% over the past three years.Reported Earnings • Jun 01Full year 2026 earnings released: EPS: ₹3.84 (vs ₹2.70 in FY 2025)Full year 2026 results: EPS: ₹3.84 (up from ₹2.70 in FY 2025). Revenue: ₹1.76b (up 8.3% from FY 2025). Net income: ₹69.1m (up 56% from FY 2025). Profit margin: 3.9% (up from 2.7% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.お知らせ • May 25Vipul Organics Limited to Report Q4, 2026 Results on May 30, 2026Vipul Organics Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 30, 2026Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: ₹1.10 (vs ₹1.11 in 3Q 2025)Third quarter 2026 results: EPS: ₹1.10. Revenue: ₹463.8m (up 12% from 3Q 2025). Net income: ₹18.5m (up 27% from 3Q 2025). Profit margin: 4.0% (up from 3.5% in 3Q 2025). The increase in margin was driven by higher revenue.お知らせ • Feb 06Vipul Organics Limited to Report Q3, 2026 Results on Feb 13, 2026Vipul Organics Limited announced that they will report Q3, 2026 results on Feb 13, 2026最新情報をもっと見るRecent updatesNew Risk • Jun 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 7.0% per year over the past 5 years. High level of non-cash earnings (25% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (₹5.14b market cap, or US$54.0m).Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹241, the stock trades at a trailing P/E ratio of 66.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 187% over the past three years.Reported Earnings • Jun 01Full year 2026 earnings released: EPS: ₹3.84 (vs ₹2.70 in FY 2025)Full year 2026 results: EPS: ₹3.84 (up from ₹2.70 in FY 2025). Revenue: ₹1.76b (up 8.3% from FY 2025). Net income: ₹69.1m (up 56% from FY 2025). Profit margin: 3.9% (up from 2.7% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.お知らせ • May 25Vipul Organics Limited to Report Q4, 2026 Results on May 30, 2026Vipul Organics Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 30, 2026Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: ₹1.10 (vs ₹1.11 in 3Q 2025)Third quarter 2026 results: EPS: ₹1.10. Revenue: ₹463.8m (up 12% from 3Q 2025). Net income: ₹18.5m (up 27% from 3Q 2025). Profit margin: 4.0% (up from 3.5% in 3Q 2025). The increase in margin was driven by higher revenue.お知らせ • Feb 06Vipul Organics Limited to Report Q3, 2026 Results on Feb 13, 2026Vipul Organics Limited announced that they will report Q3, 2026 results on Feb 13, 2026お知らせ • Dec 23Vipul Organics Limited announced that it has received INR 275.4394 million in funding from JVS Holdings LLP and other investors.On December 22, 2025, the Vipul Organics Limited closed the transaction. Company issued 1,305,400 equity shares at an issue price of INR 211 for the proceeds of INR 275,439,400.Transaction is approved by board of directors. Transaction involves participation of Jagdish N Master for 475,000 shares, Mehul Madhusudan Shah for 300,000 shares, JVS Holdings LLP for 240,000 shares, Niti Mehul Shah for 2,00,000 shares, Mihir Shah for 60,000 shares, Shanay Rajiv Shah for 10,000 shares, Malav Rajiv Shah for 10,000 shares, Milan P Shah HUF for 5,400 shares and Krupa Kubadiya for 5,000 shares.Reported Earnings • Nov 16Second quarter 2026 earnings released: EPS: ₹1.15 (vs ₹0.81 in 2Q 2025)Second quarter 2026 results: EPS: ₹1.15 (up from ₹0.81 in 2Q 2025). Revenue: ₹396.6m (up 1.1% from 2Q 2025). Net income: ₹18.1m (up 71% from 2Q 2025). Profit margin: 4.6% (up from 2.7% in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 10% per year and the company’s share price has also increased by 10% per year.お知らせ • Nov 05Vipul Organics Limited to Report Q2, 2026 Results on Nov 14, 2025Vipul Organics Limited announced that they will report Q2, 2026 results on Nov 14, 2025お知らせ • Sep 08Vipul Organics Limited, Annual General Meeting, Sep 30, 2025Vipul Organics Limited, Annual General Meeting, Sep 30, 2025, at 15:30 Indian Standard Time.Declared Dividend • Sep 08Dividend reduced to ₹0.80Dividend of ₹0.80 is 20% lower than last year. Ex-date: 23rd September 2025 Payment date: 30th October 2025 Dividend yield will be 0.4%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (30% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 2.3% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 67% to shift the payout ratio to a potentially unsustainable range, which is more than the 12% EPS decline seen over the last 5 years.お知らせ • Sep 05Vipul Organics Limited Appoints Mansi Kirankumar Shah as the Company Secretary and Compliance Officer, Effective 5 September, 2025Vipul Organics Limited, at the board meeting held on 5 September, 2025 appointed Mrs. Mansi Kirankumar Shah as the Company Secretary and Compliance Officer of the Company with effect from 5 September, 2025.Reported Earnings • Aug 16First quarter 2026 earnings released: EPS: ₹0.86 (vs ₹0.87 in 1Q 2025)First quarter 2026 results: EPS: ₹0.86. Revenue: ₹376.9m (down 1.0% from 1Q 2025). Net income: ₹12.7m (up 11% from 1Q 2025). Profit margin: 3.4% (up from 3.0% in 1Q 2025).お知らせ • Aug 09Vipul Organics Limited to Report Q1, 2026 Results on Aug 14, 2025Vipul Organics Limited announced that they will report Q1, 2026 results on Aug 14, 2025Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹2.70 (vs ₹2.60 in FY 2024)Full year 2025 results: EPS: ₹2.70 (up from ₹2.60 in FY 2024). Revenue: ₹1.63b (up 8.7% from FY 2024). Net income: ₹44.2m (up 32% from FY 2024). Profit margin: 2.7% (up from 2.2% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has remained flat, which means it is well ahead of earnings.お知らせ • May 26Vipul Organics Limited to Report Q4, 2025 Results on May 30, 2025Vipul Organics Limited announced that they will report Q4, 2025 results on May 30, 2025Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹148, the stock trades at a trailing P/E ratio of 55.7x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 8.6% over the past three years.New Risk • Apr 29New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 36% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (36% increase in shares outstanding). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₹2.42b market cap, or US$28.4m).お知らせ • Apr 03Vipul Organics Limited has completed a Follow-on Equity Offering in the amount of INR 204.115386 million.Vipul Organics Limited has completed a Follow-on Equity Offering in the amount of INR 204.115386 million. Security Name: Equity Shares Security Type: Common Stock Securities Offered: 4,437,291 Price\Range: INR 46 Transaction Features: Rights OfferingValuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹153, the stock trades at a trailing P/E ratio of 43x. Average trailing P/E is 25x in the Chemicals industry in India. Negligible returns to shareholders over past three years.New Risk • Mar 10New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 7.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (7.2% average weekly change). Earnings have declined by 14% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₹2.81b market cap, or US$32.2m).Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹152, the stock trades at a trailing P/E ratio of 42.9x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 8.3% over the past three years.Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹1.11 (vs ₹0.62 in 3Q 2024)Third quarter 2025 results: EPS: ₹1.11 (up from ₹0.62 in 3Q 2024). Revenue: ₹415.4m (up 11% from 3Q 2024). Net income: ₹14.6m (up 83% from 3Q 2024). Profit margin: 3.5% (up from 2.1% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.お知らせ • Feb 07Vipul Organics Limited to Report Q3, 2025 Results on Feb 12, 2025Vipul Organics Limited announced that they will report Q3, 2025 results on Feb 12, 2025Reported Earnings • Nov 13Second quarter 2025 earnings released: EPS: ₹0.81 (vs ₹0.77 in 2Q 2024)Second quarter 2025 results: EPS: ₹0.81 (up from ₹0.77 in 2Q 2024). Revenue: ₹394.3m (up 7.9% from 2Q 2024). Net income: ₹10.6m (up 6.5% from 2Q 2024). Profit margin: 2.7% (in line with 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings.お知らせ • Nov 09Vipul Organics Limited to Report Q2, 2025 Results on Nov 12, 2024Vipul Organics Limited announced that they will report Q2, 2025 results on Nov 12, 2024New Risk • Oct 29New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (3.0x net interest cover). Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 18% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Shareholders have been diluted in the past year (3.1% increase in shares outstanding). Market cap is less than US$100m (₹3.52b market cap, or US$41.8m).お知らせ • Oct 03Vipul Organics Limited Approves Dividend for the Financial Year Ended 31 March 2024Vipul Organics Limited announced that at its AGM held on 30 September 2024, the shareholders approved dividend of INR 1 per equity share of INR 10 each that is 10% of the paid-up equity capital of the company for the financial year ended 31 March 2024.New Risk • Sep 30New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (3.0x net interest cover). Share price has been highly volatile over the past 3 months (9.7% average weekly change). Earnings have declined by 18% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₹3.43b market cap, or US$40.9m).Declared Dividend • Sep 06Dividend increased to ₹1.00Dividend of ₹1.00 is 11% higher than last year. Ex-date: 23rd September 2024 Payment date: 30th October 2024 Dividend yield will be 0.4%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (39% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.6% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to decline by 57% to shift the payout ratio to a potentially unsustainable range, which is more than the 3.8% EPS decline seen over the last 5 years.お知らせ • Sep 03Vipul Organics Limited, Annual General Meeting, Sep 30, 2024Vipul Organics Limited, Annual General Meeting, Sep 30, 2024, at 15:30 Indian Standard Time.New Risk • Aug 15New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.7% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (3.0x net interest cover). Earnings have declined by 18% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.6% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₹3.00b market cap, or US$35.7m).Valuation Update With 7 Day Price Move • Aug 02Investor sentiment improves as stock rises 32%After last week's 32% share price gain to ₹234, the stock trades at a trailing P/E ratio of 76.9x. Average trailing P/E is 36x in the Chemicals industry in India. Total returns to shareholders of 60% over the past three years.New Risk • Jul 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (3.0x net interest cover). Earnings have declined by 18% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₹2.48b market cap, or US$29.6m).Reported Earnings • Jul 21First quarter 2025 earnings released: EPS: ₹0.87 (vs ₹0.40 in 1Q 2024)First quarter 2025 results: EPS: ₹0.87 (up from ₹0.40 in 1Q 2024). Revenue: ₹382.0m (up 5.7% from 1Q 2024). Net income: ₹11.4m (up 121% from 1Q 2024). Profit margin: 3.0% (up from 1.4% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jul 18Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹199, the stock trades at a trailing P/E ratio of 77.6x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 17% over the past three years.お知らせ • Jul 14Vipul Organics Limited to Report Q1, 2025 Results on Jul 19, 2024Vipul Organics Limited announced that they will report Q1, 2025 results on Jul 19, 2024Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹171, the stock trades at a trailing P/E ratio of 66.5x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 24% over the past three years.Reported Earnings • Jun 04Full year 2024 earnings released: EPS: ₹2.57 (vs ₹1.47 in FY 2023)Full year 2024 results: EPS: ₹2.57 (up from ₹1.47 in FY 2023). Revenue: ₹1.51b (up 13% from FY 2023). Net income: ₹33.4m (up 77% from FY 2023). Profit margin: 2.2% (up from 1.4% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.お知らせ • Jun 01Vipul Organics Limited Recommends Dividend for the Financial Year Ended March 31, 2024Vipul Organics Limited at its board meeting held on May 30, 2024 recommended the payment of dividend on Equity Shares of INR 10 each at INR 1 per share that is 10.00% of the paid up Equity Share Capital for the financial year ended March 31, 2024, subject To Approve the shareholders at the upcoming 52nd Annual General Meeting of the Company. The dividend if approved at the upcoming AGM of the Company, shall be paid/dispatched within 30 days of upcoming AGM. The date of Annual General Meeting will be intimated in due course of time.お知らせ • May 26Vipul Organics Limited to Report Q4, 2024 Results on May 30, 2024Vipul Organics Limited announced that they will report Q4, 2024 results on May 30, 2024Valuation Update With 7 Day Price Move • Mar 13Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₹158, the stock trades at a trailing P/E ratio of 79.3x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 25% over the past three years.New Risk • Feb 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.8x net interest cover). Earnings have declined by 13% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Profit margins are more than 30% lower than last year (1.8% net profit margin). Market cap is less than US$100m (₹2.93b market cap, or US$35.4m).Reported Earnings • Feb 18Third quarter 2024 earnings released: EPS: ₹0.62 (vs ₹0.06 in 3Q 2023)Third quarter 2024 results: EPS: ₹0.62 (up from ₹0.06 in 3Q 2023). Revenue: ₹374.2m (up 34% from 3Q 2023). Net income: ₹7.96m (up ₹6.89m from 3Q 2023). Profit margin: 2.1% (up from 0.4% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.お知らせ • Feb 07Vipul Organics Limited to Report Q3, 2024 Results on Feb 14, 2024Vipul Organics Limited announced that they will report Q3, 2024 results on Feb 14, 2024お知らせ • Nov 12Vipul Organics Limited Appoints Priya Shadija as Company Secretary and Compliance Officer Effective November 10, 2023Vipul Organics Limited announced that at the SGM, the board has approved the appointed of Ms. Priya Shadija as Company Secretary and Compliance Officer effective November 10, 2023.お知らせ • Nov 05Vipul Organics Limited to Report Q2, 2024 Results on Nov 10, 2023Vipul Organics Limited announced that they will report Q2, 2024 results on Nov 10, 2023New Risk • Oct 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.6x net interest cover). Earnings have declined by 6.8% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Profit margins are more than 30% lower than last year (1.0% net profit margin). Shareholders have been diluted in the past year (17% increase in shares outstanding). Market cap is less than US$100m (₹2.18b market cap, or US$26.1m).Upcoming Dividend • Sep 15Upcoming dividend of ₹0.90 per share at 0.6% yieldEligible shareholders must have bought the stock before 22 September 2023. Payment date: 30 October 2023. Payout ratio is a comfortable 61% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.3%). Lower than average of industry peers (0.8%).お知らせ • Sep 08Vipul Organics Limited, Annual General Meeting, Sep 30, 2023Vipul Organics Limited, Annual General Meeting, Sep 30, 2023, at 15:30 Indian Standard Time. Agenda: To receive, consider and adopt the Standalone Audited Financial Statements of the Company for the financial year ended 31st March, 2023 together with the reports of the Board of Directors and Auditors thereon; to declare dividend on Equity Shares for the financial year ended 31st March, 2023; to appoint a director in place of Mr. Vipul P. Shah ,who retires by rotation; and to consider other business matters.New Risk • Aug 16New major risk - Revenue and earnings growthEarnings have declined by 6.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Earnings have declined by 6.8% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (1.0% net profit margin). Shareholders have been diluted in the past year (17% increase in shares outstanding). Market cap is less than US$100m (₹1.78b market cap, or US$21.4m).Reported Earnings • Aug 15First quarter 2024 earnings released: EPS: ₹0.40 (vs ₹0.82 in 1Q 2023)First quarter 2024 results: EPS: ₹0.40 (down from ₹0.82 in 1Q 2023). Revenue: ₹362.4m (down 4.4% from 1Q 2023). Net income: ₹5.13m (down 52% from 1Q 2023). Profit margin: 1.4% (down from 2.8% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.お知らせ • Aug 06Vipul Organics Limited to Report Q1, 2024 Results on Aug 14, 2023Vipul Organics Limited announced that they will report Q1, 2024 results at 3:30 PM, Indian Standard Time on Aug 14, 2023Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹1.47 (vs ₹5.75 in FY 2022)Full year 2023 results: EPS: ₹1.47 (down from ₹5.75 in FY 2022). Revenue: ₹1.34b (flat on FY 2022). Net income: ₹18.7m (down 73% from FY 2022). Profit margin: 1.4% (down from 5.2% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.お知らせ • May 26Vipul Organics Limited to Report Q4, 2023 Results on May 30, 2023Vipul Organics Limited announced that they will report Q4, 2023 results on May 30, 2023Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. VP, Additional Whole-Time Director & CFO Mihir Shah was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Mar 29Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹85.70, the stock trades at a trailing P/E ratio of 28.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.Recent Insider Transactions • Feb 24Chairman & MD recently bought ₹2.5m worth of stockOn the 22nd of February, Vipul Shah bought around 23k shares on-market at roughly ₹108 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Vipul's only on-market trade for the last 12 months.Reported Earnings • Feb 15Third quarter 2023 earnings released: EPS: ₹0.06 (vs ₹1.26 in 3Q 2022)Third quarter 2023 results: EPS: ₹0.06 (down from ₹1.26 in 3Q 2022). Revenue: ₹278.8m (down 9.8% from 3Q 2022). Net income: ₹1.06m (down 93% from 3Q 2022). Profit margin: 0.4% (down from 4.9% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 3% per year.お知らせ • Feb 07Vipul Organics Limited to Report Q3, 2023 Results on Feb 14, 2023Vipul Organics Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 14, 2023Reported Earnings • Nov 20Second quarter 2023 earnings released: EPS: ₹0.32 (vs ₹1.40 in 2Q 2022)Second quarter 2023 results: EPS: ₹0.32 (down from ₹1.40 in 2Q 2022). Revenue: ₹368.4m (up 19% from 2Q 2022). Net income: ₹4.17m (down 75% from 2Q 2022). Profit margin: 1.1% (down from 5.4% in 2Q 2022). The decrease in margin was driven by higher expenses.お知らせ • Sep 16Vipul Organics Limited Approves Dividend for the Financial Year Ended March 31, 2022Vipul Organics Limited approved dividend of INR 10 per share for the financial year ended March 31, 2022, at its AGM held on September 14, 2022.Valuation Update With 7 Day Price Move • Sep 09Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹170, the stock trades at a trailing P/E ratio of 33.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 77% over the past three years.Upcoming Dividend • Aug 30Upcoming dividend of ₹0.90 per shareEligible shareholders must have bought the stock before 06 September 2022. Payment date: 14 October 2022. Payout ratio is a comfortable 14% but the company is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.7%). Lower than average of industry peers (0.7%).お知らせ • Aug 24Vipul Organics Limited Proposes Dividend for the Financial Year Ended March 31, 2022Vipul Organics Limited proposed dividend at the rate of 9% i.e. INR 0.90 per share on Equity Shares having face value of INR 10/- each fully paid up for the financial year ended March 31, 2022, at its AGM to be held on September 14, 2022. The same be paid to those shareholders whose names appeared on the Company's Register of Members /List of Beneficiaries as on September 7, 2022 and that the dividend be paid to those shareholders who are entitled to receive the same.お知らせ • Aug 23Vipul Organics Limited, Annual General Meeting, Sep 14, 2022Vipul Organics Limited, Annual General Meeting, Sep 14, 2022, at 16:30 Indian Standard Time.Reported Earnings • Aug 14First quarter 2023 earnings released: EPS: ₹0.82 (vs ₹1.31 in 1Q 2022)First quarter 2023 results: EPS: ₹0.82 (down from ₹1.31 in 1Q 2022). Revenue: ₹379.3m (up 17% from 1Q 2022). Net income: ₹10.6m (down 32% from 1Q 2022). Profit margin: 2.8% (down from 4.8% in 1Q 2022). The decrease in margin was driven by higher expenses.お知らせ • Aug 13Vipul Organics Limited Appoints Dheerendra Verma as Company Secretary and Compliance Office, Effective 25 August, 2022Vipul Organics Limited announced Board Meeting Outcome for Outcome of Board Meeting Held on 11.08.2022, Appointed Mr. Dheerendra Verma as Company Secretary and Compliance Officer of the Company w.e.f. 25 August, 2022 to fill vacancy caused by resignation of Mrs. Krina Sanghvi, previous Company Secretary and Compliance Officer of the Company. Mr. Dheerendra Verma is a B. Com, LLB and an Associate Member of the Institute Company Secretaries of India. He has more than 9 months of post-qualification experience in managing company secretarial matters.お知らせ • Aug 01Vipul Organics Limited Accepts the Resignation of Krina Sanghvi, Company Secretary & Compliance OfficerVipul Organics Limited accepted the resignation of Mrs. Krina Sanghvi, Company Secretary & Compliance Officer of the Company, effective closing working hours of 30 July, 2022.Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹169, the stock trades at a trailing P/E ratio of 31.1x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 48% over the past three years.Reported Earnings • Jun 05Full year 2022 earnings released: EPS: ₹5.70 (vs ₹5.74 in FY 2021)Full year 2022 results: EPS: ₹5.70. Revenue: ₹1.33b (up 12% from FY 2021). Net income: ₹69.7m (up 1.7% from FY 2021). Profit margin: 5.2% (down from 5.8% in FY 2021). The decrease in margin was driven by higher expenses.お知らせ • May 31Vipul Organics Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022Vipul Organics Limited at its board meeting held on May 30, 2022 recommended final dividend of INR 0.90 per share for the financial year ended March 31, 2022, subject to approval at annual general meeting. the dividend will be paid with in 30 days from the date of its declaration at AGM.お知らせ • May 25Vipul Organics Limited to Report Q4, 2022 Results on May 30, 2022Vipul Organics Limited announced that they will report Q4, 2022 results on May 30, 2022お知らせ • May 20Vipul Organics Limited Hires Milin Purohit to Head Their Sales and MarketingVipul Organics Limited announced that they have hired a senior Chemicals Industry hand, Mr. Milin Purohit, to head their sales and marketing. The appointment is important as Vipul Organics is looking at diversifying its products portfolio and focusing on new categories of business. Mr. Milin Purohit is an industry veteran and has over 36 years if experience. He has around 2 decades of experience in Chemicals and related businesses like epoxies, adhesives, sealants, construction chemicals and around 15 years in FMCG segment.Valuation Update With 7 Day Price Move • Apr 08Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₹221, the stock trades at a trailing P/E ratio of 44.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 54% over the past three years.Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 21% share price decline to ₹171, the stock trades at a trailing P/E ratio of 26.4x. Average forward P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 27% over the past three years.Reported Earnings • Jan 30Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.58 (down from ₹2.24 in 3Q 2021). Revenue: ₹308.9m (down 2.6% from 3Q 2021). Net income: ₹15.1m (down 30% from 3Q 2021). Profit margin: 4.9% (down from 6.8% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹209, the stock trades at a trailing P/E ratio of 28.6x. Average forward P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 14% over the past three years.Valuation Update With 7 Day Price Move • Jan 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹174, the stock trades at a trailing P/E ratio of 23.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 11% over the past three years.Upcoming Dividend • Sep 01Upcoming dividend of ₹0.90 per shareEligible shareholders must have bought the stock before 08 September 2021. Payment date: 14 October 2021. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.5%). In line with average of industry peers (0.7%).Reported Earnings • Aug 04First quarter 2022 earnings released: EPS ₹1.64 (vs ₹1.14 in 1Q 2021)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2022 results: Revenue: ₹323.8m (up 61% from 1Q 2021). Net income: ₹15.6m (up 42% from 1Q 2021). Profit margin: 4.8% (down from 5.5% in 1Q 2021). The decrease in margin was driven by higher expenses.Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹198, the stock trades at a trailing P/E ratio of 27.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 23% over the past three years.Reported Earnings • Jun 11Full year 2021 earnings released: EPS ₹7.19 (vs ₹5.98 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹1.19b (up 29% from FY 2020). Net income: ₹68.5m (up 48% from FY 2020). Profit margin: 5.7% (up from 5.0% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Jun 08Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹194, the stock trades at a trailing P/E ratio of 27.9x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 8.1% over the past three years.Valuation Update With 7 Day Price Move • Apr 10Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹199, the stock trades at a trailing P/E ratio of 28.5x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 11% over the past three years.Is New 90 Day High Low • Mar 16New 90-day high: ₹169The company is up 71% from a price of ₹98.95 on 16 December 2020. Outperformed the Indian market which is up 13% over the last 90 days. Exceeded the Chemicals industry, which is up 8.0% over the same period.Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹169, the stock trades at a trailing P/E ratio of 24.3x, up from the previous P/E ratio of 20.5x. Average P/E is 17x in the Chemicals industry in India. Total returns to shareholders over the past three years are 2.5%.Executive Departure • Mar 11Company Secretary & Compliance Officer has left the companyOn the 10th of March, Yogita Mundhra's tenure as Company Secretary & Compliance Officer ended after 2.1 years in the role. We don't have any record of a personal shareholding under Yogita's name. Yogita is the only executive to leave the company over the last 12 months.お知らせ • Feb 25Vipul Organics Limited announced that it has received INR 19.425 million in fundingOn February 23, 2021, Vipul Organics Limited (BSE:530627) closed the transaction.Reported Earnings • Feb 15Third quarter 2021 earnings released: EPS ₹2.24 (vs ₹0.47 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹318.4m (up 50% from 3Q 2020). Net income: ₹21.4m (up 484% from 3Q 2020). Profit margin: 6.7% (up from 1.7% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.お知らせ • Feb 14Vipul Organics Limited Announces Executive ChangesVipul Organics Limited announced that the Board of Directors of the Company at its meeting held on 13 February, 2021, has accepted the resignation of Ms. Yogita Mundhra, Company Secretary & Compliance Officer of the Company from closing working hours of 10 March, 2021 due to her personal reasons. The board appointed Ms. Kinjal Shah, Associate Member of the Institute of Company Secretaries of India, as the Company Secretary & Compliance Officer of the Company with effect from 11 March, 2021.Valuation Update With 7 Day Price Move • Feb 06Investor sentiment improved over the past weekAfter last week's 37% share price gain to ₹163, the stock is trading at a trailing P/E ratio of 25.6x, up from the previous P/E ratio of 18.7x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 6.4%.Is New 90 Day High Low • Feb 06New 90-day high: ₹163The company is up 79% from its price of ₹91.35 on 06 November 2020. The Indian market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹129, the stock is trading at a trailing P/E ratio of 20.2x, up from the previous P/E ratio of 17.1x. This compares to an average P/E of 19x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 28%.Is New 90 Day High Low • Jan 19New 90-day high: ₹120The company is up 22% from its price of ₹98.00 on 21 October 2020. The Indian market is also up 22% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is up 20% over the same period.Is New 90 Day High Low • Dec 29New 90-day high: ₹114The company is up 6.0% from its price of ₹107 on 30 September 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹114, the stock is trading at a trailing P/E ratio of 17.8x, up from the previous P/E ratio of 15.1x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 33%.Reported Earnings • Nov 13Second quarter 2021 earnings released: EPS ₹2.00The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹297.4m (up 40% from 2Q 2020). Net income: ₹19.5m (up 431% from 2Q 2020). Profit margin: 6.5% (up from 1.7% in 2Q 2020). The increase in margin was driven by higher revenue.Is New 90 Day High Low • Nov 04New 90-day low: ₹85.80The company is down 34% from its price of ₹130 on 06 August 2020. The Indian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.Is New 90 Day High Low • Oct 15New 90-day low: ₹96.75The company is down 21% from its price of ₹123 on 17 July 2020. The Indian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.株主還元530627IN ChemicalsIN 市場7D-4.1%-1.5%-1.1%1Y6.5%-7.4%-3.2%株主還元を見る業界別リターン: 530627過去 1 年間で-5.1 % の収益を上げたIndian Chemicals業界を上回りました。リターン対市場: 530627過去 1 年間で-1.3 % の収益を上げたIndian市場を上回りました。価格変動Is 530627's price volatile compared to industry and market?530627 volatility530627 Average Weekly Movement7.2%Chemicals Industry Average Movement6.2%Market Average Movement6.2%10% most volatile stocks in IN Market9.2%10% least volatile stocks in IN Market3.9%安定した株価: 530627 、 Indian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 530627の 週次ボラティリティ ( 7% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1968116Vipul Shahwww.vipulorganics.comVipul Organics Limitedはインドで染料、有機顔料、有機中間体の製造と販売を行っている。顔料パウダー、顔料ディスパージョン、反応染料、直接染料、酸性染料、ナフトール、ファーストカラーベース、ファーストカラーソルト、桶染料・ペースト、塩基性染料、染料・顔料用中間体、食品・湖沼用色素を提供。同社は繊維、塗料、印刷インキ、化粧品と食品、プラスチックとマスターバッチ、ゴムとラテックス、農業、皮革、紙と包装、飲料と菓子、栄養補助食品産業向けに製品を提供している。また、製品の輸出も行っている。旧社名はVipul Dyechem Limitedで、2016年7月にVipul Organics Limitedに社名変更した。Vipul Organics Limitedは1968年に設立され、インドのムンバイを拠点としている。もっと見るVipul Organics Limited 基礎のまとめVipul Organics の収益と売上を時価総額と比較するとどうか。530627 基礎統計学時価総額₹4.77b収益（TTM）₹69.10m売上高(TTM)₹1.75b69.1xPER（株価収益率2.7xP/Sレシオ530627 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計530627 損益計算書（TTM）収益₹1.75b売上原価₹1.14b売上総利益₹612.49mその他の費用₹543.39m収益₹69.10m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）3.63グロス・マージン34.92%純利益率3.94%有利子負債／自己資本比率45.2%530627 の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.3%現在の配当利回り21%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/08 03:35終値2026/07/08 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Vipul Organics Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関null nullCNI Infoxchange Ltd
New Risk • Jun 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 7.0% per year over the past 5 years. High level of non-cash earnings (25% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (₹5.14b market cap, or US$54.0m).
Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹241, the stock trades at a trailing P/E ratio of 66.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 187% over the past three years.
Reported Earnings • Jun 01Full year 2026 earnings released: EPS: ₹3.84 (vs ₹2.70 in FY 2025)Full year 2026 results: EPS: ₹3.84 (up from ₹2.70 in FY 2025). Revenue: ₹1.76b (up 8.3% from FY 2025). Net income: ₹69.1m (up 56% from FY 2025). Profit margin: 3.9% (up from 2.7% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.
お知らせ • May 25Vipul Organics Limited to Report Q4, 2026 Results on May 30, 2026Vipul Organics Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 30, 2026
Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: ₹1.10 (vs ₹1.11 in 3Q 2025)Third quarter 2026 results: EPS: ₹1.10. Revenue: ₹463.8m (up 12% from 3Q 2025). Net income: ₹18.5m (up 27% from 3Q 2025). Profit margin: 4.0% (up from 3.5% in 3Q 2025). The increase in margin was driven by higher revenue.
お知らせ • Feb 06Vipul Organics Limited to Report Q3, 2026 Results on Feb 13, 2026Vipul Organics Limited announced that they will report Q3, 2026 results on Feb 13, 2026
New Risk • Jun 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 7.0% per year over the past 5 years. High level of non-cash earnings (25% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (₹5.14b market cap, or US$54.0m).
Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹241, the stock trades at a trailing P/E ratio of 66.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 187% over the past three years.
Reported Earnings • Jun 01Full year 2026 earnings released: EPS: ₹3.84 (vs ₹2.70 in FY 2025)Full year 2026 results: EPS: ₹3.84 (up from ₹2.70 in FY 2025). Revenue: ₹1.76b (up 8.3% from FY 2025). Net income: ₹69.1m (up 56% from FY 2025). Profit margin: 3.9% (up from 2.7% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.
お知らせ • May 25Vipul Organics Limited to Report Q4, 2026 Results on May 30, 2026Vipul Organics Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 30, 2026
Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: ₹1.10 (vs ₹1.11 in 3Q 2025)Third quarter 2026 results: EPS: ₹1.10. Revenue: ₹463.8m (up 12% from 3Q 2025). Net income: ₹18.5m (up 27% from 3Q 2025). Profit margin: 4.0% (up from 3.5% in 3Q 2025). The increase in margin was driven by higher revenue.
お知らせ • Feb 06Vipul Organics Limited to Report Q3, 2026 Results on Feb 13, 2026Vipul Organics Limited announced that they will report Q3, 2026 results on Feb 13, 2026
お知らせ • Dec 23Vipul Organics Limited announced that it has received INR 275.4394 million in funding from JVS Holdings LLP and other investors.On December 22, 2025, the Vipul Organics Limited closed the transaction. Company issued 1,305,400 equity shares at an issue price of INR 211 for the proceeds of INR 275,439,400.Transaction is approved by board of directors. Transaction involves participation of Jagdish N Master for 475,000 shares, Mehul Madhusudan Shah for 300,000 shares, JVS Holdings LLP for 240,000 shares, Niti Mehul Shah for 2,00,000 shares, Mihir Shah for 60,000 shares, Shanay Rajiv Shah for 10,000 shares, Malav Rajiv Shah for 10,000 shares, Milan P Shah HUF for 5,400 shares and Krupa Kubadiya for 5,000 shares.
Reported Earnings • Nov 16Second quarter 2026 earnings released: EPS: ₹1.15 (vs ₹0.81 in 2Q 2025)Second quarter 2026 results: EPS: ₹1.15 (up from ₹0.81 in 2Q 2025). Revenue: ₹396.6m (up 1.1% from 2Q 2025). Net income: ₹18.1m (up 71% from 2Q 2025). Profit margin: 4.6% (up from 2.7% in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 10% per year and the company’s share price has also increased by 10% per year.
お知らせ • Nov 05Vipul Organics Limited to Report Q2, 2026 Results on Nov 14, 2025Vipul Organics Limited announced that they will report Q2, 2026 results on Nov 14, 2025
お知らせ • Sep 08Vipul Organics Limited, Annual General Meeting, Sep 30, 2025Vipul Organics Limited, Annual General Meeting, Sep 30, 2025, at 15:30 Indian Standard Time.
Declared Dividend • Sep 08Dividend reduced to ₹0.80Dividend of ₹0.80 is 20% lower than last year. Ex-date: 23rd September 2025 Payment date: 30th October 2025 Dividend yield will be 0.4%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (30% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 2.3% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 67% to shift the payout ratio to a potentially unsustainable range, which is more than the 12% EPS decline seen over the last 5 years.
お知らせ • Sep 05Vipul Organics Limited Appoints Mansi Kirankumar Shah as the Company Secretary and Compliance Officer, Effective 5 September, 2025Vipul Organics Limited, at the board meeting held on 5 September, 2025 appointed Mrs. Mansi Kirankumar Shah as the Company Secretary and Compliance Officer of the Company with effect from 5 September, 2025.
Reported Earnings • Aug 16First quarter 2026 earnings released: EPS: ₹0.86 (vs ₹0.87 in 1Q 2025)First quarter 2026 results: EPS: ₹0.86. Revenue: ₹376.9m (down 1.0% from 1Q 2025). Net income: ₹12.7m (up 11% from 1Q 2025). Profit margin: 3.4% (up from 3.0% in 1Q 2025).
お知らせ • Aug 09Vipul Organics Limited to Report Q1, 2026 Results on Aug 14, 2025Vipul Organics Limited announced that they will report Q1, 2026 results on Aug 14, 2025
Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹2.70 (vs ₹2.60 in FY 2024)Full year 2025 results: EPS: ₹2.70 (up from ₹2.60 in FY 2024). Revenue: ₹1.63b (up 8.7% from FY 2024). Net income: ₹44.2m (up 32% from FY 2024). Profit margin: 2.7% (up from 2.2% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
お知らせ • May 26Vipul Organics Limited to Report Q4, 2025 Results on May 30, 2025Vipul Organics Limited announced that they will report Q4, 2025 results on May 30, 2025
Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹148, the stock trades at a trailing P/E ratio of 55.7x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 8.6% over the past three years.
New Risk • Apr 29New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 36% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (36% increase in shares outstanding). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₹2.42b market cap, or US$28.4m).
お知らせ • Apr 03Vipul Organics Limited has completed a Follow-on Equity Offering in the amount of INR 204.115386 million.Vipul Organics Limited has completed a Follow-on Equity Offering in the amount of INR 204.115386 million. Security Name: Equity Shares Security Type: Common Stock Securities Offered: 4,437,291 Price\Range: INR 46 Transaction Features: Rights Offering
Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹153, the stock trades at a trailing P/E ratio of 43x. Average trailing P/E is 25x in the Chemicals industry in India. Negligible returns to shareholders over past three years.
New Risk • Mar 10New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 7.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (7.2% average weekly change). Earnings have declined by 14% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₹2.81b market cap, or US$32.2m).
Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹152, the stock trades at a trailing P/E ratio of 42.9x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 8.3% over the past three years.
Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹1.11 (vs ₹0.62 in 3Q 2024)Third quarter 2025 results: EPS: ₹1.11 (up from ₹0.62 in 3Q 2024). Revenue: ₹415.4m (up 11% from 3Q 2024). Net income: ₹14.6m (up 83% from 3Q 2024). Profit margin: 3.5% (up from 2.1% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
お知らせ • Feb 07Vipul Organics Limited to Report Q3, 2025 Results on Feb 12, 2025Vipul Organics Limited announced that they will report Q3, 2025 results on Feb 12, 2025
Reported Earnings • Nov 13Second quarter 2025 earnings released: EPS: ₹0.81 (vs ₹0.77 in 2Q 2024)Second quarter 2025 results: EPS: ₹0.81 (up from ₹0.77 in 2Q 2024). Revenue: ₹394.3m (up 7.9% from 2Q 2024). Net income: ₹10.6m (up 6.5% from 2Q 2024). Profit margin: 2.7% (in line with 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings.
お知らせ • Nov 09Vipul Organics Limited to Report Q2, 2025 Results on Nov 12, 2024Vipul Organics Limited announced that they will report Q2, 2025 results on Nov 12, 2024
New Risk • Oct 29New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (3.0x net interest cover). Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 18% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Shareholders have been diluted in the past year (3.1% increase in shares outstanding). Market cap is less than US$100m (₹3.52b market cap, or US$41.8m).
お知らせ • Oct 03Vipul Organics Limited Approves Dividend for the Financial Year Ended 31 March 2024Vipul Organics Limited announced that at its AGM held on 30 September 2024, the shareholders approved dividend of INR 1 per equity share of INR 10 each that is 10% of the paid-up equity capital of the company for the financial year ended 31 March 2024.
New Risk • Sep 30New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (3.0x net interest cover). Share price has been highly volatile over the past 3 months (9.7% average weekly change). Earnings have declined by 18% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₹3.43b market cap, or US$40.9m).
Declared Dividend • Sep 06Dividend increased to ₹1.00Dividend of ₹1.00 is 11% higher than last year. Ex-date: 23rd September 2024 Payment date: 30th October 2024 Dividend yield will be 0.4%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (39% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.6% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to decline by 57% to shift the payout ratio to a potentially unsustainable range, which is more than the 3.8% EPS decline seen over the last 5 years.
お知らせ • Sep 03Vipul Organics Limited, Annual General Meeting, Sep 30, 2024Vipul Organics Limited, Annual General Meeting, Sep 30, 2024, at 15:30 Indian Standard Time.
New Risk • Aug 15New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.7% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (3.0x net interest cover). Earnings have declined by 18% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.6% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₹3.00b market cap, or US$35.7m).
Valuation Update With 7 Day Price Move • Aug 02Investor sentiment improves as stock rises 32%After last week's 32% share price gain to ₹234, the stock trades at a trailing P/E ratio of 76.9x. Average trailing P/E is 36x in the Chemicals industry in India. Total returns to shareholders of 60% over the past three years.
New Risk • Jul 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (3.0x net interest cover). Earnings have declined by 18% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₹2.48b market cap, or US$29.6m).
Reported Earnings • Jul 21First quarter 2025 earnings released: EPS: ₹0.87 (vs ₹0.40 in 1Q 2024)First quarter 2025 results: EPS: ₹0.87 (up from ₹0.40 in 1Q 2024). Revenue: ₹382.0m (up 5.7% from 1Q 2024). Net income: ₹11.4m (up 121% from 1Q 2024). Profit margin: 3.0% (up from 1.4% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jul 18Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹199, the stock trades at a trailing P/E ratio of 77.6x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 17% over the past three years.
お知らせ • Jul 14Vipul Organics Limited to Report Q1, 2025 Results on Jul 19, 2024Vipul Organics Limited announced that they will report Q1, 2025 results on Jul 19, 2024
Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹171, the stock trades at a trailing P/E ratio of 66.5x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 24% over the past three years.
Reported Earnings • Jun 04Full year 2024 earnings released: EPS: ₹2.57 (vs ₹1.47 in FY 2023)Full year 2024 results: EPS: ₹2.57 (up from ₹1.47 in FY 2023). Revenue: ₹1.51b (up 13% from FY 2023). Net income: ₹33.4m (up 77% from FY 2023). Profit margin: 2.2% (up from 1.4% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
お知らせ • Jun 01Vipul Organics Limited Recommends Dividend for the Financial Year Ended March 31, 2024Vipul Organics Limited at its board meeting held on May 30, 2024 recommended the payment of dividend on Equity Shares of INR 10 each at INR 1 per share that is 10.00% of the paid up Equity Share Capital for the financial year ended March 31, 2024, subject To Approve the shareholders at the upcoming 52nd Annual General Meeting of the Company. The dividend if approved at the upcoming AGM of the Company, shall be paid/dispatched within 30 days of upcoming AGM. The date of Annual General Meeting will be intimated in due course of time.
お知らせ • May 26Vipul Organics Limited to Report Q4, 2024 Results on May 30, 2024Vipul Organics Limited announced that they will report Q4, 2024 results on May 30, 2024
Valuation Update With 7 Day Price Move • Mar 13Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₹158, the stock trades at a trailing P/E ratio of 79.3x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 25% over the past three years.
New Risk • Feb 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.8x net interest cover). Earnings have declined by 13% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Profit margins are more than 30% lower than last year (1.8% net profit margin). Market cap is less than US$100m (₹2.93b market cap, or US$35.4m).
Reported Earnings • Feb 18Third quarter 2024 earnings released: EPS: ₹0.62 (vs ₹0.06 in 3Q 2023)Third quarter 2024 results: EPS: ₹0.62 (up from ₹0.06 in 3Q 2023). Revenue: ₹374.2m (up 34% from 3Q 2023). Net income: ₹7.96m (up ₹6.89m from 3Q 2023). Profit margin: 2.1% (up from 0.4% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
お知らせ • Feb 07Vipul Organics Limited to Report Q3, 2024 Results on Feb 14, 2024Vipul Organics Limited announced that they will report Q3, 2024 results on Feb 14, 2024
お知らせ • Nov 12Vipul Organics Limited Appoints Priya Shadija as Company Secretary and Compliance Officer Effective November 10, 2023Vipul Organics Limited announced that at the SGM, the board has approved the appointed of Ms. Priya Shadija as Company Secretary and Compliance Officer effective November 10, 2023.
お知らせ • Nov 05Vipul Organics Limited to Report Q2, 2024 Results on Nov 10, 2023Vipul Organics Limited announced that they will report Q2, 2024 results on Nov 10, 2023
New Risk • Oct 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.6x net interest cover). Earnings have declined by 6.8% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Profit margins are more than 30% lower than last year (1.0% net profit margin). Shareholders have been diluted in the past year (17% increase in shares outstanding). Market cap is less than US$100m (₹2.18b market cap, or US$26.1m).
Upcoming Dividend • Sep 15Upcoming dividend of ₹0.90 per share at 0.6% yieldEligible shareholders must have bought the stock before 22 September 2023. Payment date: 30 October 2023. Payout ratio is a comfortable 61% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.3%). Lower than average of industry peers (0.8%).
お知らせ • Sep 08Vipul Organics Limited, Annual General Meeting, Sep 30, 2023Vipul Organics Limited, Annual General Meeting, Sep 30, 2023, at 15:30 Indian Standard Time. Agenda: To receive, consider and adopt the Standalone Audited Financial Statements of the Company for the financial year ended 31st March, 2023 together with the reports of the Board of Directors and Auditors thereon; to declare dividend on Equity Shares for the financial year ended 31st March, 2023; to appoint a director in place of Mr. Vipul P. Shah ,who retires by rotation; and to consider other business matters.
New Risk • Aug 16New major risk - Revenue and earnings growthEarnings have declined by 6.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Earnings have declined by 6.8% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (1.0% net profit margin). Shareholders have been diluted in the past year (17% increase in shares outstanding). Market cap is less than US$100m (₹1.78b market cap, or US$21.4m).
Reported Earnings • Aug 15First quarter 2024 earnings released: EPS: ₹0.40 (vs ₹0.82 in 1Q 2023)First quarter 2024 results: EPS: ₹0.40 (down from ₹0.82 in 1Q 2023). Revenue: ₹362.4m (down 4.4% from 1Q 2023). Net income: ₹5.13m (down 52% from 1Q 2023). Profit margin: 1.4% (down from 2.8% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
お知らせ • Aug 06Vipul Organics Limited to Report Q1, 2024 Results on Aug 14, 2023Vipul Organics Limited announced that they will report Q1, 2024 results at 3:30 PM, Indian Standard Time on Aug 14, 2023
Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹1.47 (vs ₹5.75 in FY 2022)Full year 2023 results: EPS: ₹1.47 (down from ₹5.75 in FY 2022). Revenue: ₹1.34b (flat on FY 2022). Net income: ₹18.7m (down 73% from FY 2022). Profit margin: 1.4% (down from 5.2% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.
お知らせ • May 26Vipul Organics Limited to Report Q4, 2023 Results on May 30, 2023Vipul Organics Limited announced that they will report Q4, 2023 results on May 30, 2023
Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. VP, Additional Whole-Time Director & CFO Mihir Shah was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Mar 29Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹85.70, the stock trades at a trailing P/E ratio of 28.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.
Recent Insider Transactions • Feb 24Chairman & MD recently bought ₹2.5m worth of stockOn the 22nd of February, Vipul Shah bought around 23k shares on-market at roughly ₹108 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Vipul's only on-market trade for the last 12 months.
Reported Earnings • Feb 15Third quarter 2023 earnings released: EPS: ₹0.06 (vs ₹1.26 in 3Q 2022)Third quarter 2023 results: EPS: ₹0.06 (down from ₹1.26 in 3Q 2022). Revenue: ₹278.8m (down 9.8% from 3Q 2022). Net income: ₹1.06m (down 93% from 3Q 2022). Profit margin: 0.4% (down from 4.9% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 3% per year.
お知らせ • Feb 07Vipul Organics Limited to Report Q3, 2023 Results on Feb 14, 2023Vipul Organics Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 14, 2023
Reported Earnings • Nov 20Second quarter 2023 earnings released: EPS: ₹0.32 (vs ₹1.40 in 2Q 2022)Second quarter 2023 results: EPS: ₹0.32 (down from ₹1.40 in 2Q 2022). Revenue: ₹368.4m (up 19% from 2Q 2022). Net income: ₹4.17m (down 75% from 2Q 2022). Profit margin: 1.1% (down from 5.4% in 2Q 2022). The decrease in margin was driven by higher expenses.
お知らせ • Sep 16Vipul Organics Limited Approves Dividend for the Financial Year Ended March 31, 2022Vipul Organics Limited approved dividend of INR 10 per share for the financial year ended March 31, 2022, at its AGM held on September 14, 2022.
Valuation Update With 7 Day Price Move • Sep 09Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹170, the stock trades at a trailing P/E ratio of 33.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 77% over the past three years.
Upcoming Dividend • Aug 30Upcoming dividend of ₹0.90 per shareEligible shareholders must have bought the stock before 06 September 2022. Payment date: 14 October 2022. Payout ratio is a comfortable 14% but the company is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.7%). Lower than average of industry peers (0.7%).
お知らせ • Aug 24Vipul Organics Limited Proposes Dividend for the Financial Year Ended March 31, 2022Vipul Organics Limited proposed dividend at the rate of 9% i.e. INR 0.90 per share on Equity Shares having face value of INR 10/- each fully paid up for the financial year ended March 31, 2022, at its AGM to be held on September 14, 2022. The same be paid to those shareholders whose names appeared on the Company's Register of Members /List of Beneficiaries as on September 7, 2022 and that the dividend be paid to those shareholders who are entitled to receive the same.
お知らせ • Aug 23Vipul Organics Limited, Annual General Meeting, Sep 14, 2022Vipul Organics Limited, Annual General Meeting, Sep 14, 2022, at 16:30 Indian Standard Time.
Reported Earnings • Aug 14First quarter 2023 earnings released: EPS: ₹0.82 (vs ₹1.31 in 1Q 2022)First quarter 2023 results: EPS: ₹0.82 (down from ₹1.31 in 1Q 2022). Revenue: ₹379.3m (up 17% from 1Q 2022). Net income: ₹10.6m (down 32% from 1Q 2022). Profit margin: 2.8% (down from 4.8% in 1Q 2022). The decrease in margin was driven by higher expenses.
お知らせ • Aug 13Vipul Organics Limited Appoints Dheerendra Verma as Company Secretary and Compliance Office, Effective 25 August, 2022Vipul Organics Limited announced Board Meeting Outcome for Outcome of Board Meeting Held on 11.08.2022, Appointed Mr. Dheerendra Verma as Company Secretary and Compliance Officer of the Company w.e.f. 25 August, 2022 to fill vacancy caused by resignation of Mrs. Krina Sanghvi, previous Company Secretary and Compliance Officer of the Company. Mr. Dheerendra Verma is a B. Com, LLB and an Associate Member of the Institute Company Secretaries of India. He has more than 9 months of post-qualification experience in managing company secretarial matters.
お知らせ • Aug 01Vipul Organics Limited Accepts the Resignation of Krina Sanghvi, Company Secretary & Compliance OfficerVipul Organics Limited accepted the resignation of Mrs. Krina Sanghvi, Company Secretary & Compliance Officer of the Company, effective closing working hours of 30 July, 2022.
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹169, the stock trades at a trailing P/E ratio of 31.1x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 48% over the past three years.
Reported Earnings • Jun 05Full year 2022 earnings released: EPS: ₹5.70 (vs ₹5.74 in FY 2021)Full year 2022 results: EPS: ₹5.70. Revenue: ₹1.33b (up 12% from FY 2021). Net income: ₹69.7m (up 1.7% from FY 2021). Profit margin: 5.2% (down from 5.8% in FY 2021). The decrease in margin was driven by higher expenses.
お知らせ • May 31Vipul Organics Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022Vipul Organics Limited at its board meeting held on May 30, 2022 recommended final dividend of INR 0.90 per share for the financial year ended March 31, 2022, subject to approval at annual general meeting. the dividend will be paid with in 30 days from the date of its declaration at AGM.
お知らせ • May 25Vipul Organics Limited to Report Q4, 2022 Results on May 30, 2022Vipul Organics Limited announced that they will report Q4, 2022 results on May 30, 2022
お知らせ • May 20Vipul Organics Limited Hires Milin Purohit to Head Their Sales and MarketingVipul Organics Limited announced that they have hired a senior Chemicals Industry hand, Mr. Milin Purohit, to head their sales and marketing. The appointment is important as Vipul Organics is looking at diversifying its products portfolio and focusing on new categories of business. Mr. Milin Purohit is an industry veteran and has over 36 years if experience. He has around 2 decades of experience in Chemicals and related businesses like epoxies, adhesives, sealants, construction chemicals and around 15 years in FMCG segment.
Valuation Update With 7 Day Price Move • Apr 08Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₹221, the stock trades at a trailing P/E ratio of 44.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 54% over the past three years.
Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 21% share price decline to ₹171, the stock trades at a trailing P/E ratio of 26.4x. Average forward P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 27% over the past three years.
Reported Earnings • Jan 30Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.58 (down from ₹2.24 in 3Q 2021). Revenue: ₹308.9m (down 2.6% from 3Q 2021). Net income: ₹15.1m (down 30% from 3Q 2021). Profit margin: 4.9% (down from 6.8% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹209, the stock trades at a trailing P/E ratio of 28.6x. Average forward P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 14% over the past three years.
Valuation Update With 7 Day Price Move • Jan 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹174, the stock trades at a trailing P/E ratio of 23.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 11% over the past three years.
Upcoming Dividend • Sep 01Upcoming dividend of ₹0.90 per shareEligible shareholders must have bought the stock before 08 September 2021. Payment date: 14 October 2021. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.5%). In line with average of industry peers (0.7%).
Reported Earnings • Aug 04First quarter 2022 earnings released: EPS ₹1.64 (vs ₹1.14 in 1Q 2021)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2022 results: Revenue: ₹323.8m (up 61% from 1Q 2021). Net income: ₹15.6m (up 42% from 1Q 2021). Profit margin: 4.8% (down from 5.5% in 1Q 2021). The decrease in margin was driven by higher expenses.
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹198, the stock trades at a trailing P/E ratio of 27.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 23% over the past three years.
Reported Earnings • Jun 11Full year 2021 earnings released: EPS ₹7.19 (vs ₹5.98 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹1.19b (up 29% from FY 2020). Net income: ₹68.5m (up 48% from FY 2020). Profit margin: 5.7% (up from 5.0% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Jun 08Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹194, the stock trades at a trailing P/E ratio of 27.9x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 8.1% over the past three years.
Valuation Update With 7 Day Price Move • Apr 10Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹199, the stock trades at a trailing P/E ratio of 28.5x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 11% over the past three years.
Is New 90 Day High Low • Mar 16New 90-day high: ₹169The company is up 71% from a price of ₹98.95 on 16 December 2020. Outperformed the Indian market which is up 13% over the last 90 days. Exceeded the Chemicals industry, which is up 8.0% over the same period.
Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹169, the stock trades at a trailing P/E ratio of 24.3x, up from the previous P/E ratio of 20.5x. Average P/E is 17x in the Chemicals industry in India. Total returns to shareholders over the past three years are 2.5%.
Executive Departure • Mar 11Company Secretary & Compliance Officer has left the companyOn the 10th of March, Yogita Mundhra's tenure as Company Secretary & Compliance Officer ended after 2.1 years in the role. We don't have any record of a personal shareholding under Yogita's name. Yogita is the only executive to leave the company over the last 12 months.
お知らせ • Feb 25Vipul Organics Limited announced that it has received INR 19.425 million in fundingOn February 23, 2021, Vipul Organics Limited (BSE:530627) closed the transaction.
Reported Earnings • Feb 15Third quarter 2021 earnings released: EPS ₹2.24 (vs ₹0.47 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹318.4m (up 50% from 3Q 2020). Net income: ₹21.4m (up 484% from 3Q 2020). Profit margin: 6.7% (up from 1.7% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
お知らせ • Feb 14Vipul Organics Limited Announces Executive ChangesVipul Organics Limited announced that the Board of Directors of the Company at its meeting held on 13 February, 2021, has accepted the resignation of Ms. Yogita Mundhra, Company Secretary & Compliance Officer of the Company from closing working hours of 10 March, 2021 due to her personal reasons. The board appointed Ms. Kinjal Shah, Associate Member of the Institute of Company Secretaries of India, as the Company Secretary & Compliance Officer of the Company with effect from 11 March, 2021.
Valuation Update With 7 Day Price Move • Feb 06Investor sentiment improved over the past weekAfter last week's 37% share price gain to ₹163, the stock is trading at a trailing P/E ratio of 25.6x, up from the previous P/E ratio of 18.7x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 6.4%.
Is New 90 Day High Low • Feb 06New 90-day high: ₹163The company is up 79% from its price of ₹91.35 on 06 November 2020. The Indian market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹129, the stock is trading at a trailing P/E ratio of 20.2x, up from the previous P/E ratio of 17.1x. This compares to an average P/E of 19x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 28%.
Is New 90 Day High Low • Jan 19New 90-day high: ₹120The company is up 22% from its price of ₹98.00 on 21 October 2020. The Indian market is also up 22% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is up 20% over the same period.
Is New 90 Day High Low • Dec 29New 90-day high: ₹114The company is up 6.0% from its price of ₹107 on 30 September 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.
Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹114, the stock is trading at a trailing P/E ratio of 17.8x, up from the previous P/E ratio of 15.1x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 33%.
Reported Earnings • Nov 13Second quarter 2021 earnings released: EPS ₹2.00The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹297.4m (up 40% from 2Q 2020). Net income: ₹19.5m (up 431% from 2Q 2020). Profit margin: 6.5% (up from 1.7% in 2Q 2020). The increase in margin was driven by higher revenue.
Is New 90 Day High Low • Nov 04New 90-day low: ₹85.80The company is down 34% from its price of ₹130 on 06 August 2020. The Indian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
Is New 90 Day High Low • Oct 15New 90-day low: ₹96.75The company is down 21% from its price of ₹123 on 17 July 2020. The Indian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.
